Clinical Transplantation Products include autologous and allogeneic hematopoietic progenitor cells derived from bone marrow or peripheral blood (apheresis product), minimally manipulated progenitor cells, and allogeneic therapeutic cells (T cells).
Manufacturing of all products is performed under Good Manufacturing Practice regulations.
External Quality Assurance monitoring is performed by Sophia Stewart, Manager, Quality Assurance and Regulatory Affairs.
